
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis is positioned for improving fundamentals because its core recurring revenue stream is already growing and early robotic catheter adoption is accelerating, with Q3 recurring revenue of $5.9M up 6% year over year and robotic catheter revenue up more than 400% from last year. The company also has clear system-side catalysts, as Q3 system sales of $3M rose 60% year over year on the first GenesisX and Synchrony revenue, while the large installed base and 100+ dedicated user accounts support a meaningful replacement cycle and broader commercialization. Although supply constraints at Osypka weighed on results and Q3 revenue of $8.9M fell short of the $9.6M estimate, management’s $24M convertible financing, $1.9M backlog, and plan for adjusted operating expenses of roughly $8M per quarter improve liquidity and support cash flow profitability by YE27.
Bears say
Stereotaxis is facing a fragile fundamental setup because it may not generate enough cash from operations and may need additional capital to sustain business activities, while hospital committees can delay or reject costly robotic system purchases. Revenue visibility has also weakened, as management cut 2026 expectations from above $40M to $35M after H1 revenue of $14M, signaling slower system sales despite a projected back-half mix of only $7M and $8M in recurring revenue. Execution risk remains elevated because innovation may lag the EP market, cybersecurity issues could hurt operations and reputation, and dependence on a concentrated shareholder base and key leader creates governance and retention risk.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Stereotaxis Inc (STXS) Forecast
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares